Clinical Cancer Research (CCR) is published twice monthly, one volume/year, by the American Association for Cancer Research, Inc. (AACR), 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106-4404.Phone: (215) 440-9300 or Toll Free: (866) 423-3965; Fax: (267) 646-0590; E-mail: pubs@aacr.org.
Scope: Clinical Cancer Research, is a journal of the American Association for Cancer Research whose focus is to publish innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. Clinical Cancer Research is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. The journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.
Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease. Clinical Cancer Research will publish articles that provide the reader with knowledge and information to impact the natural history of malignant disease by providing better care for patients with cancer.
Clinical Cancer Research is abstracted and/or indexed in Chemical Abstracts, Current Contents/CM®, Index Medicus, and MEDLINE. The journal is printed on acid-free paper in the U.S.
|
